Serum  	Serum  	 NNP	B-NP
HIF-1alpha  	HIF-1alpha  	 NNP	I-NP
and  	and  	 CC	O
VEGF  	VEGF  	 NNP	B-NP
levels  	levels  	 NNS	I-NP
pre-  	pre-  	 JJ	O
and  	and  	 CC	O
post-TACE  	post-TACE  	 JJ	B-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
primary  	primary  	 JJ	B-NP
liver  	liver  	 NN	I-NP
cancer  	cancer  	 NN	I-NP
To  	To  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
expression  	expression  	 NN	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
serum  	serum  	 JJ	I-NP
hypoxia  	hypoxia  	 JJ	I-NP
inducible  	inducible  	 JJ	I-NP
factor  	factor  	 NN	I-NP
1  	1  	 CD	O
alpha  	alpha  	 NNS	O
( 	( 	 -LRB-	O
HIF-1alpha 	HIF-1alpha 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
vascular  	vascular  	 JJ	B-NP
endothelial  	endothelial  	 JJ	I-NP
growth  	growth  	 NN	I-NP
factor  	factor  	 NN	I-NP
( 	( 	 -LRB-	O
VEGF 	VEGF 	 NNP	B-NP
)  	)  	 -RRB-	O
pre-  	pre-  	 JJ	O
and  	and  	 CC	O
post-transcatheter  	post-transcatheter  	 JJ	B-NP
arterial  	arterial  	 JJ	I-NP
chemoembolization  	chemoembolization  	 NNS	I-NP
( 	( 	 -LRB-	O
TACE 	TACE 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
primary  	primary  	 JJ	B-NP
liver  	liver  	 NN	I-NP
cancer  	cancer  	 NN	I-NP
( 	( 	 -LRB-	O
PLC 	PLC 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
correlations  	correlations  	 NN	B-NP
between  	between  	 IN	O
prognosis  	prognosis  	 JJ	B-NP
factors  	factors  	 NNS	I-NP
and  	and  	 CC	O
serum  	serum  	 JJ	B-NP
HIF-1alpha  	HIF-1alpha  	 NN	I-NP
as  	as  	 IN	O
well  	well  	 RB	O
asVEGF  	asVEGF  	 JJ	B-NP
levels 	levels 	 NNS	I-NP
.  	.  	 .	O
Forty  	Forty  	 JJ	O
consecutive  	consecutive  	 JJ	O
patients  	patients  	 NNS	O
fulfilling  	fulfilling  	 VBG	O
diagnostic  	diagnostic  	 JJ	B-NP
criteria  	criteria  	 NNS	I-NP
for  	for  	 IN	I-NP
PLC  	PLC  	 NNP	I-NP
undergoing  	undergoing  	 VBG	I-NP
TACE  	TACE  	 NNP	I-NP
from  	from  	 IN	O
March  	March  	 NNP	O
2008  	2008  	 CD	O
to  	to  	 TO	O
May  	May  	 NNP	O
2009  	2009  	 CD	O
were  	were  	 VBD	O
enrolled  	enrolled  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
study 	study 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
serum  	serum  	 JJ	B-NP
HIF-1alpha  	HIF-1alpha  	 NN	I-NP
and  	and  	 CC	O
VEGF  	VEGF  	 NNP	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
PLC  	PLC  	 NNP	I-NP
patients  	patients  	 NNS	I-NP
pre-  	pre-  	 JJ	O
and  	and  	 CC	O
1  	1  	 CD	O
day 	day 	 NN	O
,  	,  	 ,	O
1  	1  	 CD	O
week 	week 	 NN	B-NP
,  	,  	 ,	O
1  	1  	 CD	O
month  	month  	 NN	B-NP
post-TACE  	post-TACE  	 NN	I-NP
were  	were  	 VBD	O
analyzed  	analyzed  	 VBN	O
using  	using  	 VBG	O
ELISA 	ELISA 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
20  	20  	 CD	O
healthy  	healthy  	 JJ	O
volunteers 	volunteers 	 NNS	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
were  	were  	 VBD	O
divided  	divided  	 VBN	O
into  	into  	 IN	O
complete  	complete  	 JJ	B-NP
response  	response  	 NN	I-NP
( 	( 	 -LRB-	O
CR 	CR 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
partial  	partial  	 JJ	B-NP
response  	response  	 NN	I-NP
( 	( 	 -LRB-	O
PR 	PR 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
stable  	stable  	 JJ	B-NP
disease  	disease  	 NN	I-NP
( 	( 	 -LRB-	O
SD 	SD 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
progressive  	progressive  	 JJ	B-NP
disease  	disease  	 NN	I-NP
( 	( 	 -LRB-	O
PD 	PD 	 NNP	B-NP
)  	)  	 -RRB-	O
groups  	groups  	 NNS	O
according  	according  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
therapeutic  	therapeutic  	 JJ	B-NP
efficacy 	efficacy 	 NN	I-NP
.  	.  	 .	O
Pearson  	Pearson  	 NNP	B-NP
correlation  	correlation  	 NN	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
analyze  	analyze  	 VB	O
the  	the  	 DT	O
correlation  	correlation  	 NN	O
between  	between  	 IN	O
different  	different  	 JJ	O
clinical  	clinical  	 JJ	B-NP
variables  	variables  	 NNS	I-NP
and  	and  	 CC	O
serum  	serum  	 JJ	O
HIF-  	HIF-  	 JJ	B-NP
1alpha  	1alpha  	 NN	O
and  	and  	 CC	O
VEGF  	VEGF  	 NNP	B-NP
levels  	levels  	 NNS	I-NP
before  	before  	 IN	O
TACE 	TACE 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
correlation  	correlation  	 NN	O
between  	between  	 IN	O
serum  	serum  	 JJ	B-NP
HIF-1alpha  	HIF-1alpha  	 NN	I-NP
and  	and  	 CC	O
VEGF  	VEGF  	 NNP	B-NP
levels  	levels  	 NNS	I-NP
was  	was  	 VBD	O
also  	also  	 RB	O
evaluated 	evaluated 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
expression  	expression  	 NN	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
serum  	serum  	 JJ	I-NP
HIF-1alpha  	HIF-1alpha  	 NN	I-NP
and  	and  	 CC	O
VEGF  	VEGF  	 NNP	B-NP
in  	in  	 IN	O
PLC  	PLC  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
were  	were  	 VBD	O
154.94  	154.94  	 CD	O
+ 	+ 	 CD	O
/ 	/ 	 CD	O
-  	-  	 :	O
83.29  	83.29  	 CD	O
and  	and  	 CC	O
264.00  	264.00  	 CD	O
+ 	+ 	 CD	O
/ 	/ 	 CD	O
-  	-  	 :	O
148.10  	148.10  	 CD	O
pg 	pg 	 CD	B-NP
/ 	/ 	 CD	I-NP
mL  	mL  	 JJ	I-NP
pre-TACE 	pre-TACE 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
both  	both  	 DT	O
of  	of  	 IN	O
them  	them  	 PRP	O
were  	were  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
than  	than  	 IN	O
those  	those  	 DT	O
in  	in  	 IN	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
23.84  	23.84  	 NNP	O
+ 	+ 	 NNP	O
/ 	/ 	 NNP	O
-  	-  	 :	O
8.15  	8.15  	 CD	O
and  	and  	 CC	O
69.78  	69.78  	 CD	O
+ 	+ 	 CD	O
/ 	/ 	 CD	O
-  	-  	 :	O
21.42  	21.42  	 CD	O
pg 	pg 	 CD	B-NP
/ 	/ 	 CD	I-NP
mL 	mL 	 NN	I-NP
,  	,  	 ,	O
all  	all  	 DT	O
P  	P  	 NN	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
One  	One  	 CD	O
day  	day  	 NN	O
after  	after  	 IN	O
TACE 	TACE 	 NNP	B-NP
,  	,  	 ,	O
both  	both  	 DT	O
serum  	serum  	 JJ	B-NP
HIF-1alpha  	HIF-1alpha  	 NNP	I-NP
( 	( 	 -LRB-	O
570.64  	570.64  	 NNP	O
+ 	+ 	 NNP	O
/ 	/ 	 NNP	O
-  	-  	 :	O
230.87  	230.87  	 FW	O
pg 	pg 	 FW	B-NP
/ 	/ 	 FW	I-NP
mL 	mL 	 FW	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
VEGF  	VEGF  	 NNP	B-NP
levels  	levels  	 NNS	I-NP
( 	( 	 -LRB-	O
362.07  	362.07  	 NNP	O
+ 	+ 	 NNP	O
/ 	/ 	 NNP	O
-  	-  	 :	O
102.25  	102.25  	 CD	O
pg 	pg 	 CD	B-NP
/ 	/ 	 CD	I-NP
mL 	mL 	 NN	I-NP
)  	)  	 -RRB-	O
reached  	reached  	 VBD	O
the  	the  	 DT	O
peak  	peak  	 NN	B-NP
values  	values  	 NNS	I-NP
( 	( 	 -LRB-	O
all  	all  	 DT	O
P  	P  	 NN	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
One  	One  	 CD	O
week  	week  	 NN	B-NP
post-TACE 	post-TACE 	 NN	I-NP
,  	,  	 ,	O
expression  	expression  	 NN	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	O
them  	them  	 PRP	O
were  	were  	 VBD	O
decreased  	decreased  	 VBN	O
( 	( 	 -LRB-	O
198.62  	198.62  	 NNP	O
+ 	+ 	 NNP	O
/ 	/ 	 NNP	O
-  	-  	 :	O
92.11  	92.11  	 CD	O
and  	and  	 CC	O
283.52  	283.52  	 CD	O
+ 	+ 	 CD	O
/ 	/ 	 CD	O
-  	-  	 :	O
145.46  	145.46  	 FW	O
pg 	pg 	 FW	B-NP
/ 	/ 	 FW	I-NP
mL  	mL  	 FW	I-NP
respectively 	respectively 	 FW	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
but  	but  	 CC	O
still  	still  	 RB	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
than  	than  	 IN	O
those  	those  	 DT	O
before  	before  	 IN	O
TACE  	TACE  	 NNP	B-NP
( 	( 	 -LRB-	O
all  	all  	 DT	O
P  	P  	 NN	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
both  	both  	 DT	O
HIF-1alpha  	HIF-1alpha  	 NNP	B-NP
( 	( 	 -LRB-	O
133.96  	133.96  	 NNP	O
+ 	+ 	 NNP	O
/ 	/ 	 NNP	O
-  	-  	 :	O
57.02  	57.02  	 FW	O
vs.  	vs.  	 FW	O
255.74  	255.74  	 FW	O
+ 	+ 	 FW	O
/ 	/ 	 FW	O
-  	-  	 :	O
123.44  	123.44  	 FW	O
pg 	pg 	 FW	B-NP
/ 	/ 	 FW	I-NP
mL 	mL 	 FW	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
VEGF  	VEGF  	 NNP	B-NP
( 	( 	 -LRB-	O
150.96  	150.96  	 NNP	O
+ 	+ 	 NNP	O
/ 	/ 	 NNP	O
-  	-  	 :	O
84.89  	84.89  	 FW	O
vs.  	vs.  	 FW	O
368.95  	368.95  	 FW	O
+ 	+ 	 FW	O
/ 	/ 	 FW	O
-  	-  	 :	O
161.90  	161.90  	 FW	O
pg 	pg 	 FW	B-NP
/ 	/ 	 FW	I-NP
mL 	mL 	 FW	I-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
CR  	CR  	 NNP	B-NP
group  	group  	 NN	I-NP
1  	1  	 CD	O
month  	month  	 NN	B-NP
post-TACE  	post-TACE  	 NN	I-NP
were  	were  	 VBD	O
significantly  	significantly  	 RB	O
lower  	lower  	 JJR	O
than  	than  	 IN	O
those  	those  	 DT	O
in  	in  	 IN	O
PR+SD+PD  	PR+SD+PD  	 CD	B-NP
group  	group  	 NN	O
( 	( 	 -LRB-	O
all  	all  	 DT	O
P  	P  	 NN	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
level  	level  	 NN	O
of  	of  	 IN	O
serum  	serum  	 JJ	B-NP
HIF-1alpha  	HIF-1alpha  	 NN	I-NP
was  	was  	 VBD	O
positively  	positively  	 RB	O
correlated  	correlated  	 VBN	O
with  	with  	 IN	O
serum  	serum  	 JJ	B-NP
VEGF  	VEGF  	 NNP	I-NP
level  	level  	 NN	I-NP
( 	( 	 -LRB-	O
r=0.42 	r=0.42 	 NNP	O
,  	,  	 ,	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.001 	0.001 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Both  	Both  	 DT	O
serum  	serum  	 JJ	B-NP
HIF-1alpha  	HIF-1alpha  	 NN	I-NP
and  	and  	 CC	O
VEGF  	VEGF  	 NNP	B-NP
levels  	levels  	 NNS	I-NP
were  	were  	 VBD	O
observed  	observed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
correlated  	correlated  	 VBN	O
with  	with  	 IN	O
portal  	portal  	 FW	B-NP
vein  	vein  	 FW	I-NP
tumor  	tumor  	 FW	I-NP
thrombi  	thrombi  	 FW	I-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
metastasis  	metastasis  	 NNS	B-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
HIF-  	HIF-  	 JJ	B-NP
1alpha  	1alpha  	 NN	O
and  	and  	 CC	O
VEGF  	VEGF  	 NNP	B-NP
might  	might  	 MD	O
play  	play  	 VB	O
an  	an  	 DT	O
important  	important  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
relapse  	relapse  	 NN	O
of  	of  	 IN	O
PLC 	PLC 	 NNP	B-NP
.  	.  	 .	O
They  	They  	 PRP	O
might  	might  	 MD	O
be  	be  	 VB	O
considered  	considered  	 VBN	O
as  	as  	 IN	O
predictors  	predictors  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
efficacy  	efficacy  	 JJ	O
ofTACE  	ofTACE  	 JJ	O
and  	and  	 CC	O
metastasis  	metastasis  	 NN	B-NP
of  	of  	 IN	I-NP
PLC 	PLC 	 NNP	I-NP
.  	.  	 .	O
